Arcutis Biotherapeutics

Arcutis Biotherapeutics ARQT Stock

$27.42   0.328948%
Add to favorites
Market Cap
$3.47B
LOW - HIGH [24H]
$27.10 - $27.80
VOLUME [24H]
$159.78K
P/E Ratio
124.63
Earnings per share
$0.22
ISIN
US03969K1088
Price   Prediction

Arcutis Biotherapeutics Price Chart

Sorry, that's all we've gotfor now...

Arcutis Biotherapeutics (ARQT) stock price today is 27.42 USD on Tech Market Large (+0.33% on the day). Updated .

Arcutis Biotherapeutics ARQT Financial and Trading Overview

Arcutis Biotherapeutics stock price 27.42 USD
Previous Close 27.15 USD
Open 27.13 USD
Bid 19.48 USD x 200
Ask 34.8 USD x 200
Day's Range 26.84 - 27.59 USD
52 Week Range 19.3 - 34.8 USD
Volume 1.32M USD
Avg. Volume 2.63M USD
Market Cap 3.46B USD
Beta (5Y Monthly) 1.633
PE Ratio (TTM) 124.22727
EPS (TTM) 0.22 USD
Forward Dividend & Yield N/A (0%)
Ex-Dividend Date N/A
1y Target Est 40.38 USD

ARQT Valuation Measures

Enterprise Value 3.32B USD
Trailing P/E 124.22727
Forward P/E 24.975098
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) 6.7940736
Price/Book (mrq) 14.116735
Enterprise Value/Revenue 6.527
Enterprise Value/EBITDA 88.749

Trading Information

Arcutis Biotherapeutics Stock Price History

Beta (5Y Monthly) 1.633
52-Week Change -2.0078%
S&P500 52-Week Change 10.51%
52 Week High 34.8 USD
52 Week Low 19.3 USD
50-Day Moving Average 27.66 USD
200-Day Moving Average 25.4 USD

ARQT Share Statistics

Avg. Volume (3 month) 2.63M USD
Avg. Daily Volume (10-Days) 2.69M USD
Shares Outstanding 126.46M
Float 94.56M
Short Ratio 7.94
% Held by Insiders 1.79%
% Held by Institutions 117.70%
Shares Short 18.16M
Short % of Float 15.31%
Short % of Shares Outstanding 14.36%

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2025
Most Recent Quarter (mrq) September 30, 2026
Next Fiscal Year End December 31, 2026

Profitability

Profit Margin 5.87%
Operating Margin (ttm) 6.91%
Gross Margin 91.17%
EBITDA Margin 7.35%

Management Effectiveness

Return on Assets (ttm) 4.90%
Return on Equity (ttm) 14.87%

Income Statement

Revenue (ttm) 508.68M USD
Revenue Per Share (ttm) 3.92 USD
Quarterly Revenue Growth (yoy) 45.10%
Gross Profit (ttm) 463.81M USD
EBITDA 37.41M USD
Net Income Avi to Common (ttm) 29.91M USD
Diluted EPS (ttm) 0.22
Quarterly Earnings Growth (yoy) 18.80%

Balance Sheet

Total Cash (mrq) 259.46M USD
Total Cash Per Share (mrq) 2.05 USD
Total Debt (mrq) 123.82M USD
Total Debt/Equity (mrq) 50.75 USD
Current Ratio (mrq) 2.922
Book Value Per Share (mrq) 1.936

Cash Flow Statement

Operating Cash Flow (ttm) 59.96M USD
Levered Free Cash Flow (ttm) 32.62M USD

Profile of Arcutis Biotherapeutics

Country United States
State CA
City Westlake Village
Address 3027 Townsgate Road
ZIP 91361
Phone 805 418 5006
Website https://www.arcutis.com
Industry Biotechnology
Sector(s) Healthcare
Full Time Employees 354

Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. The company's lead product is ZORYVE, a topical roflumilast cream for the treatment of plaque psoriasis and atopic dermatitis. It also develops ZORYVE foam seborrheic dermatitis, and scalp and body psoriasis treatment; ARQ-234, a fusion protein that is a potent and highly selective checkpoint agonist of the CD200 receptor. The company was formerly known as Arcutis, Inc. and changed its name to Arcutis Biotherapeutics, Inc. in October 2019. Arcutis Biotherapeutics, Inc. was incorporated in 2016 and is headquartered in Westlake Village, California.

Q&A For Arcutis Biotherapeutics Stock

What is a current ARQT stock price?

Arcutis Biotherapeutics ARQT stock price today per share is 27.42 USD.

How to purchase Arcutis Biotherapeutics stock?

You can buy ARQT shares on the Tech Market Large exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Arcutis Biotherapeutics?

The stock symbol or ticker of Arcutis Biotherapeutics is ARQT.

Which industry does the Arcutis Biotherapeutics company belong to?

The Arcutis Biotherapeutics industry is Biotechnology.

How many shares does Arcutis Biotherapeutics have in circulation?

The max supply of Arcutis Biotherapeutics shares is 126.46M.

What is Arcutis Biotherapeutics Price to Earnings Ratio (PE Ratio)?

Arcutis Biotherapeutics PE Ratio is 124.63637000 now.

What was Arcutis Biotherapeutics earnings per share over the trailing 12 months (TTM)?

Arcutis Biotherapeutics EPS is 0.22 USD over the trailing 12 months.

Which sector does the Arcutis Biotherapeutics company belong to?

The Arcutis Biotherapeutics sector is Healthcare.

Arcutis Biotherapeutics ARQT included in indexes

Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
us US Tech Composite IXIC US 24268.11 USD —
-0.25
3.22B USD — 24235.01 USD — 24538.78 USD — — 3.22B USD —
us US Tech US 700 Small Cap Index NQUS700SC US 2940.71 USD —
+0.45
— — 2921.79 USD — 2953.86 USD — — — —
us Stlmt ID US Tech Biotechnology NBX US 4000.62 USD —
-1.26
— — 3927.42 USD — 4148.65 USD — — — —
us US Tech Global Select Market Com NQGS US 11952.01 USD —
-0.27
— — 11938.04 USD — 12087.35 USD — — — —
us US Tech Biotechnology NBI US 6983.43 USD —
-0.49
— — 6959.96 USD — 7076.43 USD — — — —
us US Tech Health Care IXHC US 1326.69 USD —
-0.47
— — 1322.85 USD — 1342.46 USD — — — —
$2.15T
Total marketcap
$69.46B
Total volume
BTC 58.04%   •   ETH 9.86%
Dominance
Select currency